Biologically Inspired Engineering, synbio, synthetic biology, crispr
Simons Chase 
Biosensing is the main component of the future personal area network. The Apple Watch is the most widely known biosensing device. The latest version (Series 6, released September 2020) sparkles with features that lean perpetually towards health including a class II FDA clearance for electrocardiogram for atrial fibrillation (AFib) detection and wellness-grade daily blood oxygen … Read more
Infinitus is a voice robotic process automation (VoiceRPA) company that is targeting the complexity and cost in U.S. healthcare. Another player in the healthcare robotic process automation (RPA) arena just completed a large capital raise. These RPA companies are bringing enterprise cloud/SaaS dynamism towards a much-needed re-platforming of the ailing and inefficient U.S. healthcare industry. … Read more
Insitro, an early-stage company based in South San Fracisco, CA, is a data-driven drug discovery and development company using machine learning and high-throughput biology to transform the way that drugs are discovered and delivered to patients. The company is applying state-of-the-art technologies from bioengineering to create massive data sets that enable the power of modern … Read more
Strand Therapeutics, a private company based in Massachusetts, is building a platform based on technology developed by biological engineers at MIT including scientific co-founders, Professor Ron Weiss, Ph.D., a pioneer of the field of synthetic biology, and Professor Darrell J. Irvine, Ph.D., a leading researcher of materials for immune-engineering. The co-founders sought to apply synthetic … Read more
There’s more to a tree than you may have thought. Consider the characterizations from a scientist, a philosopher and a poet. Professor Birgitta Whaley pursues novel quantum computing devices by using advanced probing methods (ie. ultrafast spectroscopy) to resolve the underlying mystery behind a biological molecule’s capacity to concurrently inhabit multiple places, times or energy … Read more
The typical physician’s office visit is the closest most Americans will come to experiencing the conditions that characterized the waste and futility of the Soviet Union. Olive AI, a private company based in Columbus, Ohio, intends to fix the problem of massive inefficiency in the U.S. healthcare industry by addressing healthcare’s most burdensome issues — … Read more
A special purpose acquisition company (SPAC) is a type of “blank-check” company that raises capital through initial public offerings (IPOs) with the intention to use the proceeds to acquire other companies at a later time. Unlike traditional IPOs, SPACs do not have commercial operations at the time of the IPO, explaining why they are referred … Read more
Decipher Biosciences, a commercial-stage precision urology oncology company, has filed with the U.S. Securities and Exchange Commission (SEC) to raise up to $100 million in an IPO. Decipher’s prostate cancer genomic testing products surface information about the underlying biology of a patient’s tumor. The company applies machine learning algorithms to help physicians improve therapy selection … Read more
Cullinan Oncology, LLC, a Cambridge, MA-based company, plans to raise about $150 million by offering 8.3 million shares at a price range of $17 to $19. At the midpoint of this range, Cullinan’s market value would be $750 million, fully diluted. The company is focused on developing a diversified pipeline of targeted oncology and immuno-oncology … Read more
Cell Squeeze® is a commercial technology designed to manipulate individual cells (ie. a patient’s own cells) through mild perturbation that leaves the cells viable after mechanoporation – or the insertion of a cargo directly into a cell’s cytosol. SQZ Biotech is the sole developer of this technology. One early application consists of a microchip that … Read more